K. Kaushal, V. Thummar, and P. Mehta, “Real-World Evaluation of Trastuzumab Emtansine Biosimilar in Early-Stage HER2-Positive Breast Cancer: Results from a Single-Center Retrospective Study in India: Real-world outcomes of T-DM1 biosimilar”, Arch Breast Cancer, vol. 13, no. 2, pp. 182–189, Apr. 2026.